Renaissance Capital logo

US IPO Week Ahead: Blue Apron, biotechs and banks

June 23, 2017
Week Ahead

Ten deals are on the IPO calendar to raise a combined $1.5 billion in the week ahead. Meal-kit delivery service Blue Apron Holdings (APRN) headlines the group, aiming to raise $480 million; five biotechs, two banks, a SPAC and an enterprise storage provider are also on deck.

IPO Calendar Link to Global Calendar  
Issuer
Business
Symbol
Exchange
Deal Size($m)
Market Cap($m)
Price Range
Shares Filed
Bookrunners
Avenue Therapeutics
New York, NY
ATXI
Nasdaq
$30
$55
$5.00 - 7.00
5,000,000
Oppenheimer & Co.
Fortress Biotech spinoff developing an IV formulation of the opioid tramadol.
Esquire Financial Holdings
Jericho, NY
ESQ
Nasdaq
$35
$106
$14.00 - 16.00
2,363,873
Sandler O'Neill
Commercial bank providing attorney-related loans with over $400 million in assets.
Mersana Therapeutics
Cambridge, MA
MRSN
Nasdaq
$75
$380
$14.00 - 16.00
5,000,000
J.P. Morgan
Cowen & Company

Early-stage biotech developing antibody drug conjugate therapies for cancers.
TPG Pace Holdings
Fort Worth, TX
TPGH.U
NYSE
$400
$500
$10.00
40,000,000
Deutsche Bank
Goldman Sachs

TPG-backed blank check company formed by Hotwire.com founder Karl Peterson.
Aileron Therapeutics
Cambridge, MA
ALRN
Nasdaq
$60
$250
$15.00 - 17.00
3,750,000
BofA Merrill
Jefferies
Biotech targeting a range of cancers using stapled peptides.
Blue Apron Holdings
New York, NY
APRN
NYSE
$480
$3,136
$15.00 - 17.00
30,000,000
Goldman Sachs
Morgan Stanley

Leading meal-kit delivery service in the US.
Byline Bancorp
Chicago, IL
BY
NYSE
$114
$573
$19.00 - 21.00
5,700,000
BofA Merrill
Keefe Bruyette
Chicago bank with 56 branches and $3.3 billion in assets.
Dova Pharmaceuticals
Durham, NC
DOVA
Nasdaq
$65
$415
$15.00 - 17.00
4,062,500
J.P. Morgan
Jefferies

Commercializing an acquired drug candidate for low blood platelets.
Tintri
Mountain View, CA
TNTR
Nasdaq
$100
$389
$10.50 - 12.50
8,700,000
Morgan Stanley
BofA Merrill

Sells all-flash arrays and software to create enterprise clouds.
Akcea Therapeutics
Cambridge, MA
AKCA
Nasdaq
$125
$692
$12.00 - 14.00
9,620,000
Cowen & Company
Stifel

Late-stage biotech developing therapies for rare lipid disorders.

Cooking up an IPO: Blue Apron targets $480 million
Blue Apron Holdings
(APRN) plans to raise $480 million at a market cap of $3.1 billion, above its most recent private valuation. While the Bessemer-backed meal-kit unicorn has become unprofitable due to increased spending on customer acquisition, its combination of size ($1 billion in run-rate) and high growth (targeting 25%+ in the near term) make it an intriguing play for investors. We note that the average VC-backed tech IPO is up 21% year-to-date.

What's in store for Tintri
Enterprise storage provider Tintri (TNTR) is scheduled to raise $100 million. The Mountain View, CA-based company has raised $260 million privately and was most recently valued at $785 million. While the IPO will value the company at $389 million, we note that post-IPO, the company will have raised a total of $360 million in funding. Like storage provider peers Pure Storage (PSTG) and Nutanix (NTNX), Tintri has racked up massive losses, but it has failed to reach the same scale ($133 million) and growth (42%).

Five biotechs coming up
Mersana Therapeutics (MRSN), Aileron Therapeutics (ALRN), Dova Pharmaceuticals (DOVA), Akcea Therapeutics (AKCA) and Avenue Therapeutics (ATXI) are set to price next week. All of the deals are marked by high insider buying. Akcea, an Ionis Pharmaceuticals spinoff, is expected to raise $125 million inthe largest deal of the group. Fortress Biotech spinoff Avenue Therapeutics, the week's smallest deal, cut its IPO range on Friday by 40%.

Banks raising money 

Esquire Financial Holdings (ESQ), a Jericho, NY-based commercial bank providing attorney-related loans, is aiming to raise $35 million, downsized from an original $38 million. Byline Bancorp (BY), a Chicago bank with 56 branches and $3.3 billion in assets aims to raise $114 million.

A blank check and cloud storage
After three SPACs priced last week, another blank check company TPG Pace Holdings (TPGH.U) is scheduled for the week ahead. The TPG-backed firm was formed by Hotwire.com founder Karl Peterson and plans to raise $400 million.

IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. The Renaissance IPO Index is up 21.9% year-to-date, ahead of the S&P 500, which is up 8.9%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Ferrari (RACE) and First Data (FDC). The Renaissance International IPO Index is up 15.2% year-to-date, while the ACWX is up 13.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Covestro and Worldpay. To find out if this is the best ETF for you, visit our IPO Investing page.

Find out why institutional investors rely on Renaissance Capital's Pre-IPO Research for these IPOs. Follow us on Twitter (@IPOtweet) for IPO news as it happens and register for our updates on the IPO market.